Each brings significant experience in strategic marketing of rare disease therapeutics and commercial operationsBOSTON, Oct. 19, 2021 (GLOBE NEWSWIRE) --...
CAMBRIDGE, Mass., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Ring Therapeutics (“Ring”), a life sciences company founded by Flagship Pioneering to...
DENVER, Oct. 19, 2021 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge”) (Nasdaq: INNV) will release its 2022 fiscal first quarter...
Company Among Sponsors of Donate Life Float at 2022 Rose Parade Samuel Lee Becker Samuel Lee Becker BELGRADE, Mont., Oct....
BETHESDA, Md., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a biotechnology company...
Important milestone achieved as part of the Company’s new corporate strategy to develop treatments for immuno-inflammatory diseases Topline results anticipated...
CINCINNATI, Oct. 19, 2021 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (“CinCor”) today announced the appointment of Mason W. Freeman, M.D.,...
FeraMAX Pd Powder 15 Package FeraMAX Pd Powder 15 Package MISSISSAUGA, Ontario, Oct. 19, 2021 (GLOBE NEWSWIRE) -- BioSyent Inc....
Tauriga 10-19-2021 Psychedelic Water Product Portfolio LAS VEGAS, Oct. 19, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc....
OREM, Utah, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), a provider of diverse products and services...
NEEDHAM, Mass., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Nasdaq: CADL), a late clinical stage biopharmaceutical company developing novel...
With a history of leading award-winning programs and improving the coordination and quality of care, Saccocio is passionate about helping...
Phase IIa to explore the effectiveness of DMT in combination with psychotherapy for the potential treatment of Major Depressive Disorder...
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information...
Researchers at Loma Linda University Health to Evaluate Pharmacokinetics, Biomarkers and Safety of STAT-205 FORT COLLINS, Colo., Oct. 19, 2021...
Proceeds to be used to advance development of synthetic biology engine and manufacturing capabilitiesRESEARCH TRIANGLE PARK, N.C., Oct. 19, 2021...
Patient accrual for the Phase 1 dose escalation clinical trial of 186RNL (ReSPECT-LM) is expected in the fourth quarter of...
SAN DIEGO, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, announced today that the...
TORONTO, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical...
Trading to commence effective with the open of business on October 19, 2021 CELEBRATION, Fla., Oct. 19, 2021 (GLOBE NEWSWIRE)...
